A cross-sectional study assessing the potential association between COVID-19 vaccination and Sensorineural Hearing Loss
Latest Information Update: 06 May 2022
At a glance
- Drugs Ad26.COV2 S (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 06 May 2022 Status changed from not stated to completed.
- 06 May 2022 New trial record
- 01 Apr 2022 Results published in the JAMA Otolaryngology-- Head and Neck Surgery